SSGSX
Price
$47.98
Change
+$0.40 (+0.84%)
Updated
Jan 30 closing price
Net Assets
6.65B
TMVAX
Price
$27.62
Change
+$0.12 (+0.44%)
Updated
Jan 30 closing price
Net Assets
115.92M
Ad is loading...

SSGSX vs TMVAX

Header iconSSGSX vs TMVAX Comparison
Open Charts SSGSX vs TMVAXBanner chart's image
Victory Sycamore Small Company Opp A
Price$47.98
Change+$0.40 (+0.84%)
VolumeN/A
Net Assets6.65B
RBC Microcap Value A
Price$27.62
Change+$0.12 (+0.44%)
VolumeN/A
Net Assets115.92M
SSGSX vs TMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SSGSX vs. TMVAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSGSX is a StrongBuy and TMVAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 6.65B vs. TMVAX (116M). TMVAX pays higher dividends than SSGSX: TMVAX (0.85) vs SSGSX (0.35). SSGSX was incepted earlier than TMVAX: SSGSX (26 years) vs TMVAX (21 years). SSGSX is a more actively managed with annual turnover of: 32.00 vs. TMVAX (30.00). TMVAX has a lower initial minimum investment than SSGSX: TMVAX (1000) vs SSGSX (2500). TMVAX annual gain was more profitable for investors over the last year : 8.28 vs. SSGSX (3.54). TMVAX return over 5 years is better than : 14.02 vs. SSGSX (11.94).
SSGSXTMVAXSSGSX / TMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years21 years-
Gain YTD2.4771.927129%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets6.65B116M5,730%
Annual Yield % from dividends0.350.8542%
Returns for 1 year3.548.2843%
Returns for 3 years-1.87-7.7724%
Returns for 5 years11.9414.0285%
Returns for 10 years28.906.76428%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTXAX12.380.17
+1.39%
Russell Inv Tax-Managed Real Assets A
PRWCX35.820.16
+0.45%
T. Rowe Price Capital Appreciation
HDGBX24.08N/A
N/A
Hartford Dividend and Growth HLS IB
BCAIX32.19N/A
N/A
Boston Common ESG Impact Intl
LFGQX37.26N/A
N/A
Lord Abbett Focused Growth R3